NYSE · Medical - Instruments & Supplies

ALC (ALC) Stock

$71.75 -0.43% NYSE: ALC Healthcare

Valuation

MetricValue
Price$71.75
Market Cap$34.99B
P/E Ratio55.39
P/B Ratio1.62
P/S Ratio3.27
EPS (TTM)$1.98
52-Week High$87.64
52-Week Low$61.84
Dividend Yield0.50%

Financials & Margins

MetricValue
ROE2.91%
ROA2.06%
ROCE3.95%
Gross Margin24.53%
Operating Margin13.08%
Net Margin5.95%
Debt/Equity0.25
Current Ratio2.12

Annual Financials (USD)

Metric20212022202320242025
Revenue$8.3B$8.7B$9.5B$9.9B$10.4B
Operating Profit$580.0M$672.0M$1.0B$1.4B$1.4B
Net Profit$376.0M$335.0M$974.0M$1.0B$980.0M
EPS$0.76$0.68$1.96$2.05$1.98
Op Margin7.0%7.7%11.0%14.3%13.1%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$28.0B$29.2B$29.6B$30.3B$31.6B
Total Liabilities$8.7B$9.5B$9.0B$8.8B$9.5B
Cash$1.6B$980.0M$1.1B$1.7B$1.5B
Borrowings$4.5B$5.1B$5.1B$5.1B$5.2B

Latest News

IART Stock Surges 52.1% in a Year: What's Driving the Rally? Zacks · Jul 15, 2026 Will Zimmer Biomet’s New Asia Pacific Leader Reframe Its Robotics-Led Growth Story (ZBH)? Simply Wall St. · Jul 15, 2026 Thermo Fisher Set to Report Q2 Earnings: What's in the Cards? Zacks · Jul 15, 2026 Mexican Gold Mining Corp. to Effect Share Consolidation and Name Change and Announces Closing of $2,299,000 Subscription Receipt Financing TMX Newsfile · Jul 14, 2026 Buy 3 AI-Led Medical Devices Laggards of 1H Set to Gather Pace in 2H Zacks · Jul 14, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$1.3B$1.2B$1.4B$2.1B$2.3B
Investing Cash Flow$-2.4B$-2.6B$-1.9B$-1.8B$-2.0B
Financing Cash Flow$-6.0M$-113.0M$-88.0M$-55.0M$-857.0M
Net Cash Flow$18.0M$-595.0M$114.0M$582.0M$-149.0M
Free Cash Flow$165.0M$472.0M$537.0M$1.4B$1.6B

Valuation & Return Ratios

MetricValue
PEG Ratio-1.38
EV / EBITDA18.79
FCF Yield4.79%
Quick Ratio1.30
Interest Coverage5.30
Return 1Y-8.91%
Return 3Y-14.49%
Return 5Y-9.84%

Ownership

Insiders Held0.17%
Institutions Held66.43%
Institutions Float Held66.55%
Institutional HolderSharesReport Date
Bank Of New York Mellon Corporation15,669,6622026-03-31
Vanguard Capital Management LLC14,871,6072026-03-31
FMR, LLC12,426,9922026-03-31
Aristotle Capital Management, LLC10,584,3742026-03-31
AKO Capital LLP9,324,6562026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
A $149.93 -2.36% 30.48 $42.35B 0.66%
BDX $187.12 -0.53% 57.29 $51.56B 2.21%
CAH $239.35 +2.02% 32.79 $56.06B 0.86%
GEHC $70.42 -1.14% 20.45 $31.81B 0.20%
HUM $394.58 +2.96% 36.72 $47.38B 0.91%

About ALC

ALC is led by CEO David J. Endicott, employs 25,599 people, headquartered in Geneva, CH, publicly traded since 2019.

ALC stock trades at $71.75 with a market capitalization of $34.99B. The stock is valued at a price-to-earnings (P/E) ratio of 55.39, price-to-book of 1.62, price-to-sales of 3.27. Over the past 52 weeks the stock has ranged between $61.84 and $87.64, and currently trades 18.1% below its 52-week high. It pays a dividend yielding 0.50%.

On profitability, ALC generates a return on equity (ROE) of 2.91%, return on capital employed of 3.95%, an operating margin of 13.08%, a net profit margin of 5.95%.

In its most recent fiscal year, ALC reported annual revenue of $10.4B, net profit of $980.0M, revenue has compounded at 8.8% a year over the last five years.

The balance sheet shows a debt-to-equity ratio of 0.25 — a conservative balance sheet with little leverage risk, a current ratio of 2.12, total assets of $31.6B, $1.5B in cash and equivalents.

ALC has an average daily trading volume of 2,101,916 shares, a beta of 0.69 (less volatile than the overall market).

Related Healthcare Stocks

LLY Drug Manufacturers - General $1159.93 +0.28% JNJ Drug Manufacturers - General $271.19 +2.01% ABBV Drug Manufacturers - General $259.99 +1.39% MRK Drug Manufacturers - General $149.94 +1.48% UNH Medical - Healthcare Plans $396.30 +1.77% NVS Drug Manufacturers - General $161.25 +6.04% AZN Drug Manufacturers - General $162.47 +0.21% AMGN Drug Manufacturers - General $438.12 +1.92% TMO Medical - Diagnostics & Research $600.50 -2.69% NVO Biotechnology $45.12 -0.46% ABT Medical - Devices $108.97 -1.26% GILD Drug Manufacturers - General $149.92 +2.45%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides